Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Other Working Capital Changes (2016 - 2025)

Immucell (ICCC) has disclosed Other Working Capital Changes for 16 consecutive years, with -$9274.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes rose 94.33% year-over-year to -$9274.0, compared with a TTM value of $170087.0 through Sep 2025, up 142.14%, and an annual FY2024 reading of -$24287.0, down 28.01% over the prior year.
  • Other Working Capital Changes was -$9274.0 for Q3 2025 at Immucell, down from $8202.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $292852.0 in Q3 2022 and bottomed at -$220184.0 in Q4 2023.
  • Average Other Working Capital Changes over 5 years is $4132.5, with a median of -$2787.0 recorded in 2021.
  • Peak annual rise in Other Working Capital Changes hit 849.19% in 2022, while the deepest fall reached 37251.77% in 2022.
  • Year by year, Other Working Capital Changes stood at -$481.0 in 2021, then crashed by 37251.77% to -$179662.0 in 2022, then fell by 22.55% to -$220184.0 in 2023, then skyrocketed by 172.26% to $159110.0 in 2024, then crashed by 105.83% to -$9274.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for ICCC at -$9274.0 in Q3 2025, $8202.0 in Q2 2025, and $12049.0 in Q1 2025.